SCHEMBL777080

SCHEMBL777080

CCC(=O)OC(=O)C(F)C(F)F

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.35
ALDH1A1 P00352 4/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
BLM P54132 1/20 0.32
WRN Q14191 1/20 0.32
HIF1A Q16665 1/20 0.32
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29180360 1.00 NAAA (0.35) NAAAALDH1A1MGAMGAASI
SCHEMBL29034630 0.84 NAAA (0.31) NAAA
SCHEMBL25244994 0.79
SCHEMBL777079 0.79
SCHEMBL775327 0.78 NAAA (0.37) NAAAALDH1A1MGAMGAASI
SCHEMBL25239507 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL28884150 0.77 NAAA (0.31) NAAA
SCHEMBL27962452 0.76 NAAA (0.35) NAAAALDH1A1MGAMGAASI
SCHEMBL25285341 0.76 ALDH1A1 (0.30) ALDH1A1
SCHEMBL25282298 0.76 HTT (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110408314-B Preparation method of solvent-free static conductive anticorrosive paint for oil storage tank 宜兴汉光高新石化有限公司 2021-06-25 CN claimed
EP-0494967-A4 CHIRAL SEPARATION MEDIA 1993-03-17 EP claimed
EP-0494967-A1 CHIRAL SEPARATION MEDIA ADVANCED SEPARATION TECHNOLOGIES, INC. (US) 1992-07-22 EP claimed
WO-1992002283-A1 CHIRAL SEPARATION MEDIA ADVANCED SEPARATION TECHNOLOGIES INC. (US) 1992-02-20 WO claimed
US-5064944-A Gas Chromatography ADVANCED SEPARATION TECHNOLOGIES INC. (US) 1991-11-12 US claimed
US-12435086-B2 Synthesis of heterocyclic compounds PLEXXIKON INC. (US) 2025-10-07 US disclosed
EP-3709426-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME MITSUBISHI CHEM CORP (JP) 2025-02-26 EP disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
US-20240217965-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS PLEXXIKON INC. 2024-07-04 US disclosed
CN-111919326-B Electrolyte, electrochemical device, lithium ion secondary battery, assembly, and compound 大金工业株式会社 2024-06-11 CN disclosed
CN-113490674-B Compound, additive for electrolyte, electrochemical device, lithium ion secondary battery, and module 大金工业株式会社 2024-06-07 CN disclosed
CN-118026845-A Fluoroacetate compound 大金工业株式会社 2024-05-14 CN disclosed
US-20120070731-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-03-22 US disclosed
US-20090325065-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2009-12-31 US disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed
EP-0494967-A4 CHIRAL SEPARATION MEDIA 1993-03-17 EP disclosed
US-5154738-A Passing mixture through gas chromatography column having dialkyl trifluoroacyl ether derivative of cyclodextrin, eluting separated compounds ADVANCED SEPARATION TECHNOLOGIES, INC. (US) 1992-10-13 US disclosed
EP-0494967-A1 CHIRAL SEPARATION MEDIA ADVANCED SEPARATION TECHNOLOGIES, INC. (US) 1992-07-22 EP disclosed
WO-1992002283-A1 CHIRAL SEPARATION MEDIA ADVANCED SEPARATION TECHNOLOGIES INC. (US) 1992-02-20 WO disclosed
US-5064944-A Gas Chromatography ADVANCED SEPARATION TECHNOLOGIES INC. (US) 1991-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217965-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS CBR3, CBR1, CCNL2 NAAA 2732/4885ALDH1A1 2145/4885MGAM 4291/4885
US-12435086-B2 Synthesis of heterocyclic compounds CBR3, CBR1, CCNL2 NAAA 2732/4885ALDH1A1 2145/4885MGAM 4291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.